NCT00062478 2020-03-12
Study of Karenitecin (BNP1350) in Patients With Brain Tumors
BioNumerik Pharmaceuticals, Inc.
Phase 2 Completed
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc.
GOG Foundation
Alliance for Clinical Trials in Oncology
H. Lee Moffitt Cancer Center and Research Institute